Human rhabdosarcoma cell-induced aggregation of blood platelets.

Abstract:

:The ability of tumor cells shed into the circulation to cause adhesion and aggregation of blood platelets may be involved in successful metastasis of primary tumors. Rhabdosarcoma is a rare, early metastasizing tumor previously uncharacterized for ability to alter platelet function. It was found that human rhabdosarcoma cells (American Type Culture Collection) dose dependently induce biphasic aggregation of human blood platelets in heparinized platelet-rich plasma; aggregation responses could also be elicited in citrated plasma. Aggregation caused by rhabdosarcoma can be inhibited by apyrase treatment of either rhabdosarcoma or platelets, and by pretreatment of platelets with prostacyclin, cilostamide, inhibitors of thromboxane A2 production, or TMB-8; only apyrase and prostacyclin inhibited both phases of aggregation. Tumor cell supernatant contained only enough ADP to cause a negligible, reversible aggregation response. Hirudin, verapamil, and triazolam do not inhibit rhabdosarcoma-induced aggregation. Aggregation of platelets by rhabdosarcoma cells thus appears to involve ADP, from tumor cells and/or platelets, and platelet calcium mobilization and thromboxane A2 synthesis and release.

journal_name

Cancer Res

journal_title

Cancer research

authors

Longenecker GL,Beyers BJ,Bowen RJ,King T

subject

Has Abstract

pub_date

1989-01-01 00:00:00

pages

16-9

issue

1

eissn

0008-5472

issn

1538-7445

journal_volume

49

pub_type

杂志文章
  • Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.

    abstract::Mucin 1 (MUC1), a bound mucin glycoprotein, is overexpressed and aberrantly glycosylated in >80% of human ductal pancreatic carcinoma. Evidence suggests that MUC1 can be used as a tumor marker and is a potential target for immunotherapy of pancreatic cancer. However, vaccination with MUC1 peptides fails to stimulate t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-4313

    authors: Deguchi T,Tanemura M,Miyoshi E,Nagano H,Machida T,Ohmura Y,Kobayashi S,Marubashi S,Eguchi H,Takeda Y,Ito T,Mori M,Doki Y,Sawa Y

    更新日期:2010-07-01 00:00:00

  • Identification of the MEK1(F129L) activating mutation as a potential mechanism of acquired resistance to MEK inhibition in human cancers carrying the B-RafV600E mutation.

    abstract::Although targeting the Ras/Raf/MEK pathway remains a promising anticancer strategy, mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitors in clinical development are likely to be limited in their ability to produce durable clinical responses due to the emergence of acquired drug...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-4351

    authors: Wang H,Daouti S,Li WH,Wen Y,Rizzo C,Higgins B,Packman K,Rosen N,Boylan JF,Heimbrook D,Niu H

    更新日期:2011-08-15 00:00:00

  • Mesothelioma associated with the shipbuilding industry in coastal Virginia.

    abstract::A case-control study was undertaken to clarify reasons for a four-fold increased incidence of mesothelioma discovered among white males in coastal Tidewater, Va., from 1972 to 1978. Sixty-one cases were identified. Interviews with next of kin revealed that the excess was linked to employment in area shipyards. Three-f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tagnon I,Blot WJ,Stroube RB,Day NE,Morris LE,Peace BB,Fraumeni JF Jr

    更新日期:1980-11-01 00:00:00

  • Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.

    abstract::Metastasis is the process by which tumor cells spread from their site of origin to distant sites after gaining access to the circulatory system. An understanding of the factors contributing to the metastatic potential of breast cancer cells to bone will enhance the prospect of developing new therapies that impede meta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bendre MS,Gaddy-Kurten D,Mon-Foote T,Akel NS,Skinner RA,Nicholas RW,Suva LJ

    更新日期:2002-10-01 00:00:00

  • Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice.

    abstract::One-week-old male and female mice of the A, BALB/c (C), and C3H/He (C3) strains and of the AC3 and CC3 F1 hybrids were treated with a single dose (300 mg/kg s.c.) of urethan and then kept without further treatment until 30 and 40 weeks (males) or 30 and 65 weeks (females). The degree of difference in susceptibility to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dragani TA,Manenti G,Della Porta G

    更新日期:1991-12-01 00:00:00

  • Effects of dietary vitamin B6 on the in vitro inactivation of rat tyrosine aminotransferase in host liver and Morris hepatomas.

    abstract::Control rats or rats bearing Morris hepatoma 5123C (intact), 5123C (adrenalectomized), 7794A, 7800, 8999, 9121, or 9618A were fed a purified diet either deficient or adequate for vitamin B6. The concentration of pyridoxal phosphate in the plasma, host livers, and hepatomas was determined, as well as the in vitro rate ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reynolds RD,Morris HP

    更新日期:1979-08-01 00:00:00

  • Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.

    abstract::Exposure of HeLa cells to 0.2 mM O6-methylguanine for 4 h or longer led to a 70-80% loss in the activity of the DNA-repair protein, O6-alkylguanine-DNA alkyltransferase. The decline in alkyltransferase activity brought about by O6-methylguanine was reversible on removing the base but at least 48 h were required for co...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dolan ME,Morimoto K,Pegg AE

    更新日期:1985-12-01 00:00:00

  • Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer.

    abstract::Akt activation has been implicated broadly in tumorigenesis, but the basis for its dysregulation in cancer cells is incompletely understood. In this study, we sought to clarify a regulatory role for the Akt-binding carboxy-terminal modulator protein (CTMP), which has been controversial. In evaluating CTMP expression i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0518

    authors: Liu YP,Liao WC,Ger LP,Chen JC,Hsu TI,Lee YC,Chang HT,Chen YC,Jan YH,Lee KH,Zeng YH,Hsiao M,Lu PJ

    更新日期:2013-10-15 00:00:00

  • Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.

    abstract::The renal handling of cis-diamminedichloroplatinum (CP) was investigated by measuring the renal clearance of creatinine, inulin, and free platinum in ten cancer patients. Free platinum clearances exceeded the glomerular filtration rate in all time periods. For example, at 1 to 2 hr, the mean clearance of free platinum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jacobs C,Coleman CN,Rich L,Hirst K,Weiner MW

    更新日期:1984-08-01 00:00:00

  • Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.

    abstract::Using computerized pharmacy records from 1969 to 1973 for a cohort of 143,574 members of the Kaiser Permanente Medical Care Program, we have been testing associations of 215 drugs or drug groups with subsequent incidence of cancer at 56 sites. This paper presents findings with follow-up through 1984. There were 227 st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Selby JV,Friedman GD,Fireman BH

    更新日期:1989-10-15 00:00:00

  • 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.

    abstract::To assess the in vivo behavior of cytotoxic agents linked to antibodies, deferoxamine, known to form stable chelates with 67Ga, was conjugated with monoclonal antibodies using three different methods. One method used a homocoupling reagent, glutaraldehyde, whereas two other methods used heterocoupling reagents, N-succ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Koizumi M,Endo K,Kunimatsu M,Sakahara H,Nakashima T,Kawamura Y,Watanabe Y,Saga T,Konishi J,Yamamuro T

    更新日期:1988-03-01 00:00:00

  • Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non-Small Cell Lung Cancer.

    abstract::Clinical efficacy of PD-1/PD-L1 targeting relies upon the reactivation of tumor-specific but functionally impaired PD-1+ T cells present before therapy. Thus, analyzing early-stage primary tumors may reveal the presence of T cells that are not yet functionally impaired. In this study, we report that activated (HLA-DR+...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1387

    authors: Tassi E,Grazia G,Vegetti C,Bersani I,Bertolini G,Molla A,Baldassari P,Andriani F,Roz L,Sozzi G,Pastorino U,Mortarini R,Anichini A

    更新日期:2017-02-15 00:00:00

  • Reassessment of the role of dietary fat in cancer etiology.

    abstract::The role of dietary fat in cancer etiology is briefly discussed in terms of several major types of epidemiological evidence: geographic correlations, migrant studies, low-risk populations, and dietary modification trials. It appears that there is no conclusive evidence that lowering dietary fat intake will result in l...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Enstrom JE

    更新日期:1981-09-01 00:00:00

  • Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456).

    abstract::Pyrazine diazohydroxide (PZDH) is a novel antineoplastic agent that appears to form DNA adducts via the reactive pyrazine diazonium ion and produces substantial antitumor activity in preclinical models. We conducted a phase I trial to determine the maximally tolerated dose of PZDH that could be administered as a 5-min...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Vogelzang NJ,Mick R,Janisch L,Berezin F,Schilsky RL,Ratain MJ

    更新日期:1994-01-01 00:00:00

  • Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer.

    abstract::Pentraxin-3 (PTX3) is a member of the pentraxin family of innate immune regulators, which includes C-reactive protein (CRP). PTX3 has been implicated in angiogenesis, proliferation, and immune escape in cancer. In the present study, we evaluated PTX3 tissue expression and serum concentration as a biomarker to discrimi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0369

    authors: Stallone G,Cormio L,Netti GS,Infante B,Selvaggio O,Fino GD,Ranieri E,Bruno F,Prattichizzo C,Sanguedolce F,Tortorella S,Bufo P,Grandaliano G,Carrieri G

    更新日期:2014-08-15 00:00:00

  • Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.

    abstract::The induction of epidermal ornithine decarboxylase (EC 4.1.1.17) (ODC) following topical application of the tumor-promoting agent 12-O-tetradecanoylphorbol-13-acetate (TPA) to mice can be inhibited by topical application of putrescine, the product of the enzyme. The degree of inhibition depended on both the dose and t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weekes RG,Verma AK,Boutwell RK

    更新日期:1980-11-01 00:00:00

  • ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.

    abstract::Two opposing clusters of transcription factors (TF) have been associated with the differential risks of estrogen receptor positive or negative breast cancers, but the mechanisms underlying the opposing functions of the two clusters are undefined. In this study, we identified NFIB and YBX1 as novel interactors of the e...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-1153

    authors: Campbell TM,Castro MAA,de Oliveira KG,Ponder BAJ,Meyer KB

    更新日期:2018-01-15 00:00:00

  • Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.

    abstract::Primary central nervous system lymphoma (PCNSL) that arises in immune-deficient patients is an aggressive B-cell neoplasm that is universally associated with the EBV. Patients with EBV(+) PCNSL face a particularly poor prognosis with median survival times of 2-12 months despite aggressive management with radiation the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Roychowdhury S,Peng R,Baiocchi RA,Bhatt D,Vourganti S,Grecula J,Gupta N,Eisenbeis CF,Nuovo GJ,Yang W,Schmalbrock P,Ferketich A,Moeschberger M,Porcu P,Barth RF,Caligiuri MA

    更新日期:2003-03-01 00:00:00

  • Hyperalimentation in the undernourished cancer patient.

    abstract::Serial anthropometrics, creatinine-height ratios. serum albumin levels, and elemental balances were compared for cachectic cancer and noncancer patients receiving hyperalimentation. Cancer patients compared unfavorably in all measurements except triceps skinfold increments, which were equal for both groups, suggesting...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nixon DW

    更新日期:1982-01-01 00:00:00

  • A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction.

    abstract::A quantitative assessment of rate-limiting steps in metastasis has always been challenging because of the difficulty of detecting small tumor cell populations. We have developed a highly sensitive assay for monitoring the metastatic dissemination of human tumor cells in the chick embryo and used this assay to investig...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zijlstra A,Mellor R,Panzarella G,Aimes RT,Hooper JD,Marchenko ND,Quigley JP

    更新日期:2002-12-01 00:00:00

  • Monoclonal antibodies to glycoproteins of Vinca alkaloid-resistant human leukemic cells.

    abstract::Drug resistance is a major problem in the successful treatment of cancer. Resistance to one drug is often associated with cross-resistance to other anticancer agents. This is commonly seen with the "natural product" anticancer drugs such as the Vinca alkaloids and anthracyclines. In experimental systems, specific chan...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Danks MK,Metzger DW,Ashmun RA,Beck WT

    更新日期:1985-07-01 00:00:00

  • Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells.

    abstract::Solid tumor metastasis often involves detachment of epithelial carcinoma cells into the vasculature or lymphatics. However, most studies of cytoskeletal rearrangement in solid tumors focus on attached cells. In this study, we report for the first time that human breast tumor cells produce unique tubulin-based protrusi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6589

    authors: Whipple RA,Balzer EM,Cho EH,Matrone MA,Yoon JR,Martin SS

    更新日期:2008-07-15 00:00:00

  • Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones.

    abstract::Asian diets high in soy are associated with lower risk for breast cancer compared with Western diets. Moreover, higher levels of two putative carcinogenic metabolites of 17beta-estradiol, 4- and 16alpha-hydroxyestrogen, and lower amounts of anticarcinogenic metabolites, 2-hydroxyestrogens, have been associated with gr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu LJ,Cree M,Josyula S,Nagamani M,Grady JJ,Anderson KE

    更新日期:2000-03-01 00:00:00

  • Chemical synthesis of radiolabeled bleomycin A2 and its binding to DNA.

    abstract::A method for the preparation of biologically active [3H]- and [13C]bleomycin A2 is described. Demethyl Cu(II):bleomycin A2, isolated after pyrolysis of Cu(II):bleomycin A2, was methylated with either [3H]-or [13C]methyl iodide, which resulted in Cu(II):bleomycin A2 labeled in the dimethylsulfonium moiety. Copper was r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Roy SN,Orr GA,Brewer CF,Horwitz SB

    更新日期:1981-11-01 00:00:00

  • Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells.

    abstract::Dendritic epidermal T-cells (DETC) are a unique population of T-cells that reside normally in mouse epidermis and express a gamma delta T-cell receptor. We have reported previously that DETC acquire in culture the capacity to lyse the YAC-1 lymphoma, a conventional target for natural killer cells. The aim of the prese...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kaminski MJ,Cruz PD Jr,Bergstresser PR,Takashima A

    更新日期:1993-09-01 00:00:00

  • Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells.

    abstract::The influence of gangliosides on tumor growth and frequency of metastasis in vivo as well as on growth and motility of neoplastic cells in vitro was tested utilizing human and rodent cell populations. In mice receiving injections of a ganglioside mixture twice daily the tumor volume, the number of spontaneous metastas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alessandri G,Filippeschi S,Sinibaldi P,Mornet F,Passera P,Spreafico F,Cappa PM,Gullino PM

    更新日期:1987-08-15 00:00:00

  • The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.

    abstract::Spy1A is a unique cell cycle activator known to mediate cell cycle progression and override the DNA damage response. This study focused on determining the role of this protein on postnatal mammary gland morphogenesis and neoplasia. Herein, we show that Spy1A levels are tightly regulated during mammary gland developmen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6453

    authors: Golipour A,Myers D,Seagroves T,Murphy D,Evan GI,Donoghue DJ,Moorehead RA,Porter LA

    更新日期:2008-05-15 00:00:00

  • Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.

    abstract::Aberrant methylation of promoter CpG islands (CGI) is involved in silencing of tumor suppressor genes and is also a potential cancer biomarker. Here, to identify CGIs aberrantly methylated in human melanomas, we did a genome-wide search using methylation-sensitive representational difference analysis. CGIs in putative...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0157

    authors: Furuta J,Nobeyama Y,Umebayashi Y,Otsuka F,Kikuchi K,Ushijima T

    更新日期:2006-06-15 00:00:00

  • Nuclear factor-kappaB, an unappreciated tumor suppressor.

    abstract::The notion that nuclear factor-kappaB (NF-kappaB) is a tumor-promoting transcription factor has become a widely accepted dogma in biology. However, recent findings suggest an inhibitory role for NF-kappaB in carcinogenesis and tumorigenesis. Although the tumor suppressor-like effect of NF-kappaB remains to be rigorous...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-07-1576

    authors: Chen F,Castranova V

    更新日期:2007-12-01 00:00:00

  • Inhibition of phorbol ester-induced phenotypic differentiation of HL-60 cells by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a protein kinase inhibitor.

    abstract::To identify the possible role of calcium ions in cell differentiation, we studied the extracellular Ca2+ requirement and the effect of Ca2+/phospholipid-dependent protein kinase (protein kinase C) inhibitor on proliferation and differentiation of human promyelocytic leukemic HL-60 cells. HL-60 cells grew equally well ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Matsui T,Nakao Y,Koizumi T,Katakami Y,Fujita T

    更新日期:1986-02-01 00:00:00